Catheter-directed, low-dose fibrinolysis safe, effective for PE

Catheter-directed, low-dose fibrinolysis safe, effective for PE

(HealthDay)—Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis appears safe and efficacious for acute massive and submassive pulmonary embolism (PE), according to a study published in the Aug. 24 issue of JACC: Cardiovascular Interventions.

Gregory Piazza, M.D., from Brigham and Women's Hospital in Boston, and colleagues conducted a prospective, single-arm, multicenter trial to examine the safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis using the EkoSonic Endovascular System. One hundred fifty patients with acute massive or submassive (31 and 119, respectively) PE were included. Tissue-plasminogen activator (24 mg) was administered as either 1 mg/hour for 24 hours with a unilateral catheter or as 1 mg/hour/catheter for 12 hours with bilateral catheters.

The researchers found that from baseline to 48 hours post-procedure, the mean right ventricular/left ventricular diameter ratio decreased (1.55 versus 1.13; P < 0.0001). Post-procedure there were also decreases in mean pulmonary artery systolic pressure and modified Miller Index score (both P < 0.0001). In 15 patients, there was one Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO)-defined severe bleed and 16 GUSTO-defined moderate bleeding events. There were no cases of intracranial hemorrhage.

"Ultrasound-facilitated, catheter-directed, low-dose decreased right ventricular dilation, reduced pulmonary hypertension, decreased anatomic thrombus burden, and minimized in patients with acute massive and submassive PE," the authors write.

Several authors disclosed financial ties to pharmaceutical and medical device companies, including EKOS, which developed and manufactured the EkoSonic Endovascular System.

Explore further

Analysis finds mixed results for use of thrombolytic therapy for blood clot in lungs

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Catheter-directed, low-dose fibrinolysis safe, effective for PE (2015, August 25) retrieved 13 November 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments